The Value of Breast-Conserving Surgery Combined with Neoadjuvant Therapy for Breast Cancer

  • Zhu Wu Jingzhou First People's Hospital
  • Zhuo Wang Jingzhou First People's Hospital
  • Qingqing Ye Jingzhou First People's Hospital
  • Rong Fan Jingzhou First People's Hospital
Keywords: Breast Cancer, Breast-Conserving Surgery, Neoadjuvant Therapy, Value Analysis


Objective: To observe the efficacy of different methods in the treatment of breast cancer disease. Methods: A sample of 78 patients attending the clinic from 2020.8 to 2023.1 was randomly selected and divided into groups A and B. Thirty-nine patients each underwent conventional breast-conserving surgery and group B combined with neoadjuvant therapy to compare the effectiveness of treatment between the groups. Results: The overall efficiency of group B vs group A was 94.87% vs 71.79%, a significant difference (P < 0.05). Surgery-related indicators were better in Group B than in Group A (P < 0.05). Conclusion: Early intervention with breast-conserving surgery combined with neoadjuvant therapy is recommended for patients with breast cancer and has demonstrated high clinical value.


[1] Yuan S. L.,Chen Y.,Wang Y. Recent efficacy and prognosis analysis of plastic breast-conserving surgery for early breast cancer [J]. Chinese aesthetic medicine, 2022,31(12):33-35.

[2] Wang L. Effectiveness of plastic breast-conserving surgery in the treatment of early breast cancer[J]. China Medical Guide, 2022, 20(28):45-48.

[3] Wang JB, Zheng RS. Advances in neoadjuvant endocrine therapy for breast cancer[J]. Journal of Bengbu Medical College, 2009,34(11):1048-1050.
Original Research Article